Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 549-554

  Yang, Rongxi ^a,b   Dick, Michelle ^a,b   Marme, Frederik ^a   Schneeweiss, Andreas ^a   Langheinz, Anne ^a,b   Hemminki, Kari ^b,c   Sutter, Christian ^a   Bugert, Peter ^a   Wappenschmidt, Barbara ^d   Varon, Raymonda ^e   Schott, Sarah ^a   Weber, Bernhard H F ^f   Niederacher, Dieter ^g   Arnold, Norbert ^h   Meindl, Alfons ⁱ   Bartram, Claus R ^a   Schmutzler, Rita K ^d   Müller, Heiko ^b   Arndt, Volker ^b   Brenner, Hermann ^b   Sohn, Christof ^a   Burwinkel, Barbara ^a,b   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF COLOGNE   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; Genetic variants; miRNA; Polymorphism; SNP

Indexed keywords

MICRORNA; MIR 126; MIR 335; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA DEGRADATION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MICRORNAS; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; YOUNG ADULT;

EID: 79958219309     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1244-x     Document Type: Article

References (40)

1. D Baek J Villen C Shin FD Camargo SP Gygi DP Bartel 2008 The impact of microRNAs on protein output Nature 455 64 71 18668037 10.1038/nature07242 1:CAS:528:DC%2BD1cXhtVKrsbjF
2. Y Zeng R Yi BR Cullen 2003 MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms Proc Natl Acad Sci USA 100 9779 9784 12902540 10.1073/pnas.1630797100 1:CAS:528:DC%2BD3sXmvVejtLo%3D (Pubitemid 37087018)
3. M Selbach B Schwanhausser N Thierfelder Z Fang R Khanin N Rajewsky 2008 Widespread changes in protein synthesis induced by microRNAs Nature 455 58 63 18668040 10.1038/nature07228 1:CAS:528:DC%2BD1cXhtVKrsbnK
4. D Baltimore MP Boldin RM O'Connell DS Rao KD Taganov 2008 MicroRNAs: new regulators of immune cell development and function Nat Immunol 9 839 845 18645592 10.1038/ni.f.209 1:CAS:528:DC%2BD1cXoslCmu78%3D (Pubitemid 352038302)
5. J Brennecke DR Hipfner A Stark RB Russell SM Cohen 2003 Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila Cell 113 25 36 12679032 10.1016/S0092-8674(03)00231-9 1:CAS:528:DC%2BD3sXjtVWqsL0%3D (Pubitemid 36411957)
6. TC Chang EA Wentzel OA Kent K Ramachandran M Mullendore KH Lee G Feldmann M Yamakuchi M Ferlito CJ Lowenstein, et al. 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Mol Cell 26 745 752 17540599 10.1016/j.molcel.2007.05.010 1:CAS:528:DC%2BD2sXnt1Cquro%3D (Pubitemid 46856245)
7. GA Calin A Cimmino M Fabbri M Ferracin SE Wojcik M Shimizu C Taccioli N Zanesi R Garzon RI Aqeilan, et al. 2008 MiR-15a and miR-16-1 cluster functions in human leukemia Proc Natl Acad Sci USA 105 5166 5171 18362358 10.1073/pnas.0800121105 1:CAS:528:DC%2BD1cXksVCqs70%3D (Pubitemid 351738528)
8. M Dews A Homayouni D Yu D Murphy C Sevignani E Wentzel EE Furth WM Lee GH Enders JT Mendell, et al. 2006 Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat Genet 38 1060 1065 16878133 10.1038/ng1855 1:CAS:528:DC%2BD28XovVWjsbk%3D (Pubitemid 44325933)
9. C Xiao K Rajewsky 2009 MicroRNA control in the immune system: basic principles Cell 136 26 36 19135886 10.1016/j.cell.2008.12.027 1:CAS:528:DC%2BD1MXhtFOisbw%3D
10. CM Croce 2009 Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 704 714 19763153 10.1038/nrg2634 1:CAS:528:DC%2BD1MXhtFCqurjE
11. SM Khoshnaw AR Green DG Powe IO Ellis 2009 MicroRNA involvement in the pathogenesis and management of breast cancer J Clin Pathol 62 422 428 19398594 10.1136/jcp.2008.060681 1:CAS:528:DC%2BD1MXmtFais7k%3D
12. SM Johnson H Grosshans J Shingara M Byrom R Jarvis A Cheng E Labourier KL Reinert D Brown FJ Slack 2005 RAS is regulated by the let-7 microRNA family Cell 120 635 647 15766527 10.1016/j.cell.2005.01.014 1:CAS:528: DC%2BD2MXis1yhsbs%3D (Pubitemid 40343076)
13. L He JM Thomson MT Hemann E Hernando-Monge D Mu S Goodson S Powers C Cordon-Cardo SW Lowe GJ Hannon, et al. 2005 A microRNA polycistron as a potential human oncogene Nature 435 828 833 15944707 10.1038/nature03552 1:CAS:528:DC%2BD2MXkvVGgs70%3D (Pubitemid 40839734)
14. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 839 843 15944709 10.1038/nature03677 (Pubitemid 40839736)
15. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 259 269 16557279 10.1038/nrc1840 1:CAS:528: DC%2BD28XivVyqtrs%3D
16. MS Kumar J Lu KL Mercer TR Golub T Jacks 2007 Impaired microRNA processing enhances cellular transformation and tumorigenesis Nat Genet 39 673 677 17401365 10.1038/ng2003 1:CAS:528:DC%2BD2sXksFersLo%3D (Pubitemid 46676103)
17. GA Calin CM Croce 2006 MicroRNA signatures in human cancers Nat Rev Cancer 6 857 866 17060945 10.1038/nrc1997 1:CAS:528:DC%2BD28XhtFWhs7fM (Pubitemid 44629897)
18. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando, et al. 2005 MicroRNA expression profiles classify human cancers Nature 435 834 838 15944708 10.1038/nature03702 1:CAS:528:DC%2BD2MXkvVGgsLc%3D (Pubitemid 40839735)
19. TJ Key PK Verkasalo E Banks 2001 Epidemiology of breast cancer Lancet Oncol 2 133 140 11902563 10.1016/S1470-2045(00)00254-0 1:STN:280: DC%2BD387ntFelsw%3D%3D (Pubitemid 33585924)
20. J Belkora DH Moore DW Hutton 2009 Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical? Patient Educ Couns 76 106 112 19118973 10.1016/j.pec.2008.11.012
21. BA Ponder 2001 Cancer genetics Nature 411 336 341 11357140 10.1038/35077207 1:CAS:528:DC%2BD3MXktVSjsr4%3D (Pubitemid 32467042)
22. PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder 2002 Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33 36 11984562 10.1038/ng853 1:CAS:528:DC%2BD38Xjt1Kgu7g%3D
23. SF Tavazoie C Alarcon T Oskarsson D Padua Q Wang PD Bos WL Gerald J Massague 2008 Endogenous human microRNAs that suppress breast cancer metastasis Nature 451 147 152 18185580 10.1038/nature06487 1:CAS:528:DC%2BD1cXksVGhuw%3D%3D
24. R Duan C Pak P Jin 2007 Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA Hum Mol Genet 16 1124 1131 17400653 10.1093/hmg/ddm062 1:CAS:528:DC%2BD2sXntVKqsb8%3D (Pubitemid 47062732)
25. K Jazdzewski EL Murray K Franssila B Jarzab DR Schoenberg A de la Chapelle 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad Sci USA 105 7269 7274 18474871 10.1073/pnas.0802682105 1:CAS:528:DC%2BD1cXmsFCqsLo%3D (Pubitemid 351754467)
26. J Shen CB Ambrosone RA DiCioccio K Odunsi SB Lele H Zhao 2008 A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis Carcinogenesis 29 1963 1966 18660546 10.1093/carcin/bgn172 1:CAS:528:DC%2BD1cXht1SitLrN
27. R Yang B Schlehe K Hemminki C Sutter P Bugert B Wappenschmidt J Volkmann R Varon BH Weber D Niederacher, et al. 2010 A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk Breast Cancer Res Treat 121 693 702 19921425 10.1007/s10549-009-0633-5
28. S Tchatchou A Jung K Hemminki C Sutter B Wappenschmidt P Bugert BH Weber D Niederacher N Arnold R Varon-Mateeva, et al. 2009 A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women Carcinogenesis 30 59 64 19028706 10.1093/carcin/bgn253 1:CAS:528:DC%2BD1MXhtVaqu7s%3D
29. M Wu N Jolicoeur Z Li L Zhang Y Fortin D L'Abbe Z Yu SH Shen 2008 Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs Carcinogenesis 29 1710 1716 18356149 10.1093/carcin/bgn073 1:CAS:528:DC%2BD1cXhtV2jsL%2FN
30. A Meindl 2002 Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population Int J Cancer 97 472 480 11802209 10.1002/ijc.1626 1:CAS:528:DC%2BD38XkvFegtg%3D%3D (Pubitemid 34027806)
31. V Arndt T Sturmer C Stegmaier H Ziegler A Becker H Brenner 2003 Provider delay among patients with breast cancer in Germany: a population-based study J Clin Oncol 21 1440 1446 12697864 10.1200/JCO.2003.08.071 (Pubitemid 46594093)
32. M Widschwendter S Apostolidou E Raum D Rothenbacher H Fiegl U Menon C Stegmaier IJ Jacobs H Brenner 2008 Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study PLoS One 3 e2656 18628976 10.1371/journal.pone.0002656
33. L Gao MN Weck A Michel M Pawlita H Brenner 2009 Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology Cancer Res 69 2973 2980 19318564 10.1158/0008-5472.CAN-08-3477 1:CAS:528:DC%2BD1MXjvVWisLc%3D
34. WD Dupont WD Plummer Jr 1998 Power and sample size calculations for studies involving linear regression Control Clin Trials 19 589 601 9875838 10.1016/S0197-2456(98)00037-3 1:STN:280:DyaK1M%2FptFSnsA%3D%3D (Pubitemid 29057724)
35. JE Fish MM Santoro SU Morton S Yu RF Yeh JD Wythe KN Ivey BG Bruneau DY Stainier D Srivastava 2008 miR-126 regulates angiogenic signaling and vascular integrity Dev Cell 15 272 284 18694566 10.1016/j.devcel.2008.07.008 1:CAS:528:DC%2BD1cXhtVertLrL
36. B Liu XC Peng XL Zheng J Wang YW Qin 2009 MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo Lung Cancer 66 169 175 19223090 10.1016/j.lungcan.2009.01.010
37. NR Markham M Zuker 2005 DINAMelt web server for nucleic acid melting prediction Nucleic Acids Res 33 W577 W581 15980540 10.1093/nar/gki591 1:CAS:528:DC%2BD2MXlsl2jsr4%3D (Pubitemid 44529988)
38. BC Christensen M Avissar-Whiting LG Ouellet RA Butler HH Nelson MD McClean CJ Marsit KT Kelsey 2010 Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer Clin Cancer Res 16 3713 3720 20501619 10.1158/1078-0432.CCR-10-0657 1:CAS:528:DC%2BC3cXovVantrs%3D
39. HC Lee JG Kim YS Chae SK Sohn BW Kang JH Moon SW Jeon MH Lee KH Lim JY Park, et al. 2010 Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer J Cancer Res Clin Oncol 136 1073 1078 20044760 10.1007/s00432-009-0754-6 1:CAS:528:DC%2BC3cXmtlyis7Y%3D
40. P Qi TH Dou L Geng FG Zhou X Gu H Wang CF Gao 2010 Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection Hum Immunol 71 621 626 20188135 10.1016/j.humimm.2010.02.017 1:CAS:528:DC%2BC3cXmtFWitbk%3D